Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jun;156(3):535-41.
doi: 10.1111/j.1365-2249.2009.03922.x.

Decreased numbers of circulating plasmablasts and differences in IgA1-plasmablast homing to skin in coeliac disease and dermatitis herpetiformis

Affiliations

Decreased numbers of circulating plasmablasts and differences in IgA1-plasmablast homing to skin in coeliac disease and dermatitis herpetiformis

J M Kantele et al. Clin Exp Immunol. 2009 Jun.

Abstract

The two clinical phenotypes of gluten enteropathy, coeliac disease (CD) and dermatitis herpetiformis (DH), were characterized for numbers and homing profiles of circulating final effector B cells, plasmablasts, identified as immunoglobulin (Ig)-secreting cells (ISC). In CD, the numbers of ISC were approximately 50% lower than in DH or controls. ISC expressed peripheral lymph node homing receptor (HR), L-selectin, less frequently in CD (54%) and DH (52%) patients than in controls (70%). The expression of gut mucosal HR, alpha(4)beta(7), was less frequent in CD (42%) than in DH (65%) or controls (60%). In DH, but not in CD or controls, a higher proportion of IgA1-ISC (40%) than IgA2-ISC (25%) expressed the skin HR, cutaneous lymphocyte-associated antigen. In gluten enteropathy circulating plasmablasts are more mature, but decreased in number, and have distorted homing profiles. Differential IgA1-plasmablast homing could be associated with the development of skin rash with IgA1-deposits in DH but not in CD.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Circulating effector B cells in gluten enteropathies. The number of immunoglobulin-secreting cells in immunoglobulin (Ig)A-, IgM- and IgG-isotypes among peripheral blood mononuclear cells in patients with coeliac disease, dermatitis herpetiformis and in healthy controls. Error bars indicate standard error of mean. Asterisks indicate statistical significance by Student's t-test (*P < 0·05; **P < 0·01; ***P < 0·001).
Fig. 2
Fig. 2
The expression of various homing receptors and adhesion molecules on circulating immunoglobulin-secreting cells of different isotypes in coeliac disease, dermatitis herpetiformis and in healthy controls. Error bars indicate standard deviation. The numbers of volunteers from whom the data were pooled are given under each bar. (a) α4β7-integrin, (b) L-selectin, (c) α4-chain. Asterisks indicate statistical significance by Student's t-test (*P < 0·05; **P < 0·01; ***P < 0·001).
Fig. 3
Fig. 3
The expression of homing receptors on immunoglobulin (Ig)A1- and IgA2-secreting cells in coeliac disease, dermatitis herpetiformis and in healthy controls. Error bars indicate standard deviation. The numbers of volunteers from whom the data were pooled are given under each bar. (a) α4β7-integrin, (b) cutaneous lymphocyte-associated antigen, (c) L-selectin, (d) αeβ7-integrin. Asterisks indicate statistical significance by paired Student's t-test (*P < 0·05; **P < 0·01; ***P < 0·001).

References

    1. Green PHR, Jabri B. Celiac disease. Annu Rev Med. 2006;57:207–21. - PubMed
    1. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology. 2000;119:234–42. - PubMed
    1. Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol. 2002;2:647–55. - PubMed
    1. Fry L. Dermatitis herpetiformis. Baillières Clin Gastroenterol. 1995;9:371–93. - PubMed
    1. Reunala T. Dermatitis herpetiformis – coeliac disease of the skin. Ann Med. 1998;30:416–18. - PubMed

Publication types